Mark Throsby
Impact in
- Epidemiology top 1%
- Influenza Virus Research Studies
- Virology top 5%
- Rabies epidemiology and control
Papers in
- Oncology 10
- HER2/EGFR in Cancer Research 4
- Cancer Immunotherapy and Biomarkers 3
-
- Monoclonal and Polyclonal Antibodies Research 9
- Co-authors
- Jaap Goudsmit (12 shared papers)Mandy A. C. Jongeneelen (9 shared papers)Gira Bhabha (1 shared paper)Ian A. Wilson (1 shared paper)Damian C. Ekiert (1 shared paper)Marc‐André Elsliger (1 shared paper)John de Kruif (18 shared papers)Arjen Q. Bakker (3 shared papers)
- Journals
- Endocrinology (7 papers)Journal of Virology (5 papers)The Journal of Immunology (2 papers)Cancer Cell (2 papers)Investigational New Drugs (1 paper)
- Partner nations
- NetherlandsUnited StatesFrance
In The Last Decade
Mark Throsby
42 papers receiving 3.9k citations
Mark Throsby's Hit Papers
Peers
Comparison fields: 5 of 81
- Epidemiology 1.6k
- Virology 182
- Radiology, Nuclear Medicine and Imaging 519
- Oncology 382
- Immunology 318
Countries citing papers authored by Mark Throsby
This map shows the geographic impact of Mark Throsby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Throsby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Throsby more than expected).
Fields of papers citing papers by Mark Throsby
This network shows the impact of papers produced by Mark Throsby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Throsby. The network helps show where Mark Throsby may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Throsby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antibody Recognition of a Highly Conserved Influenza Virus Epitope Hit paper breakdown → | 2009 | 1165 |
| 2 | Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells Hit paper breakdown → | 2008 | 661 |
| 3 | 2004 | 221 | |
| 4 | 2013 | 163 | |
| 5 | 2007 | 151 | |
| 6 | 2006 | 144 | |
| 7 | 2005 | 136 | |
| 8 | 2022 | 126 | |
| 9 | 2000 | 108 | |
| 10 | 2018 | 98 | |
| 11 | 2015 | 95 | |
| 12 | 2021 | 91 | |
| 13 | 2009 | 88 | |
| 14 | 2005 | 81 | |
| 15 | 1998 | 73 | |
| 16 | 2006 | 73 | |
| 17 | 1998 | 61 | |
| 18 | 2019 | 60 | |
| 19 | 2004 | 52 | |
| 20 | 2012 | 37 |
About Mark Throsby
Mark Throsby is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Immunology, Virology and Spectroscopy, having authored 42 papers that have together received 4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), Mosquito-borne diseases and control (5 papers), T-cell and B-cell Immunology (4 papers), HER2/EGFR in Cancer Research (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Influenza Virus Research Studies (3 papers), Pancreatic function and diabetes (3 papers) and Diabetes and associated disorders (3 papers). The work is most often cited by research in Epidemiology (1.6k citations), Virology (182 citations), Radiology, Nuclear Medicine and Imaging (519 citations), Oncology (382 citations) and Immunology (318 citations). Mark Throsby has collaborated with scholars based in Netherlands, United States and France. Frequent co-authors include Jaap Goudsmit, Mandy A. C. Jongeneelen, Gira Bhabha, Ian A. Wilson, Damian C. Ekiert, Marc‐André Elsliger, John de Kruif, Arjen Q. Bakker, Mireille Dardenne and Jan ter Meulen. Their work appears in journals such as Endocrinology, Journal of Virology, The Journal of Immunology, Cancer Cell and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.